Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$328M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Target
TGT
|
+$155M |
| 5 |
Walt Disney
DIS
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.92% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NE
1501
DELISTED
Noble Corporation
NE
| $2.79M | 0.01% |
84,614
-21,549
| -20% | -$732K |
|
|
HRG
1502
DELISTED
HRG Group, Inc.
HRG
| $2.79M | 0.01% |
269,100
+84,800
| +46% | +$751K |
|
|
NP
1503
DELISTED
Neenah, Inc. Common Stock
NP
| $2.79M | 0.01% |
70,900
+37,027
| +109% | +$1.39M |
|
|
UBNK
1504
DELISTED
UNITIED FINANCIAL BANCORP INC
UBNK
| $2.79M | 0.01% |
172,300
-22,958
| -12% | -$368K |
|
|
MAG
1505
DELISTED
MAGNETEK INC COM STK NEW
MAG
| $2.77M | 0.01% |
156,190
+1,400
| +0.9% | +$24.9K |
|
|
CBPO
1506
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $2.76M | 0.01% |
94,500
+9,700
| +11% | +$242K |
|
1507
Brookfield
BN
$110B
| $2.76M | 0.01% |
+315,013
| New | +$2.69M |
|
1508
GSI Technology
GSIT
$258M
| $2.75M | 0.01% |
391,879
+49,179
| +14% | +$330K |
|
1509
Tetra Tech
TTEK
$9.34B
| $2.75M | 0.01% |
+531,600
| New | +$2.55M |
|
1510
Veru
VERU
$45.9M
| $2.75M | 0.01% |
27,920
+6,930
| +33% | +$640K |
|
1511
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $2.75M | 0.01% |
+68,400
| New | +$2.71M |
|
|
ZNH
1512
DELISTED
China Southern Airlines Company Limited
ZNH
| $2.73M | 0.01% |
145,800
-5,400
| -4% | -$103K |
|
|
RNDY
1513
DELISTED
ROUNDYS INC COM STK
RNDY
| $2.73M | 0.01% |
317,100
+265,800
| +518% | +$2.37M |
|
|
EPAX
1514
DELISTED
Ambassadors Group Inc
EPAX
| $2.72M | 0.01% |
788,998
+12,086
| +2% | +$42.2K |
|
|
TCF
1515
DELISTED
TCF Financial Corporation
TCF
| $2.72M | 0.01% |
190,500
+105,500
| +124% | +$1.57M |
|
|
KSPN
1516
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
| $2.71M | 0.01% |
29,250
+6,135
| +27% | +$595K |
|
|
AVEO
1517
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.7M | 0.01% |
130,875
+9,139
| +8% | +$209K |
|
1518
NextEra Energy
NEE
$179B
| $2.69M | 0.01% |
+134,400
| New | +$2.77M |
|
|
TSYS
1519
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
| $2.66M | 0.01% |
1,086,700
+143,031
| +15% | +$379K |
|
|
FLNA
1520
Filana Therapeutics
FLNA
$45.9M
| $2.65M | 0.01% |
139,240
-1,042
| -0.7% | -$18.2K |
|
|
GSH
1521
DELISTED
Guangshen Railway Co. Ltd
GSH
| $2.64M | 0.01% |
99,500
+4,800
| +5% | +$112K |
|
|
CIR
1522
DELISTED
CIRCOR International, Inc
CIR
| $2.64M | 0.01% |
42,400
-6,300
| -13% | -$362K |
|
1523
Stoneridge
SRI
$200M
| $2.63M | 0.01% |
243,587
-225,969
| -48% | -$2.79M |
|
|
SNDK
1524
DELISTED
SANDISK CORP
SNDK
| $2.63M | 0.01% |
44,199
-6,200
| -12% | -$364K |
|
1525
Waterstone Financial
WSBF
$384M
| $2.63M | 0.01% |
284,148
+47,592
| +20% | +$454K |
|
Similar funds
Jim Simons's Q3 2013 Portfolio in Review
As of Q3 2013, Jim Simons held 3,196 positions worth $41.2B, up 8.1% from $38.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q3 2013 filing shows 439 new, 1,284 increased, 1,031 reduced and 412 closed positions. Its largest new stake was GE Aerospace: 1,361,721 shares worth $156M. The largest sale was Apple, an estimated $283M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q3 2013 buy was GE Aerospace: 1,361,721 shares worth $156M.
- Jim Simons added most to IBM in Q3 2013, an estimated $328M increase.
- Jim Simons's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $211M.
- Jim Simons fully exited Apple in Q3 2013, selling an estimated $283M.
- Jim Simons's ten largest holdings make up 11% of its $41.2B portfolio in Q3 2013.
- Jim Simons opened 439 new positions and closed 412 in Q3 2013.
- Jim Simons's portfolio value rose 8.1% quarter-over-quarter to $41.2B.
Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.